Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lynch

Showing results (731-740 of 864) with videos related to

Pageof 87
Sort By:
Cancer Research|April 3, 2008
Origins and prevalence of the American Founder Mutation of MSH2Mark Clendenning, Mark E Baze, Shuying Sun, et al.
International Journal of Cancer|March 22, 2022
Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholdsGordon P Watt, Julia A Knight, Tuong L Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancerDebra G B Leonard, Lois B Travis, Kathakali Addya, et al.
Blood|March 1, 2007
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survivalJames R Cerhan, Sophia Wang, Matthew J Maurer, et al.
Emerging Infectious Diseases|April 23, 2014
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United StatesMartin Steinau, Mona Saraiya, Marc T Goodman, et al.
JAMA Network Open|January 9, 2025
Breast Cancer Susceptibility Gene Sequence Variations and Development of Contralateral Breast CancerAnne S Reiner, Gordon P Watt, Kathleen E Malone, et al.
Diseases of the Colon and Rectum|March 25, 2000
Hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in UruguayC Sarroca, N Alfano, G T Bendin, et al.
Journal of the National Cancer Institute|November 1, 2007
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term riskAnil K Chaturvedi, Eric A Engels, Ethel S Gilbert, et al.
Breast Cancer Research and Treatment|July 15, 2009
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE StudyJane C Figueiredo, Robert W Haile, Leslie Bernstein, et al.
Obstetrics and Gynecology|May 3, 2014
Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based populationAbdulrahman K Sinno, Mona Saraiya, Trevor D Thompson, et al.
Pageof 87

Showing results (731-740 of 864) with videos related to

Sort By:
Pageof 87
Cancer Research|April 3, 2008
Origins and prevalence of the American Founder Mutation of MSH2Mark Clendenning, Mark E Baze, Shuying Sun, et al.
International Journal of Cancer|March 22, 2022
Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholdsGordon P Watt, Julia A Knight, Tuong L Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancerDebra G B Leonard, Lois B Travis, Kathakali Addya, et al.
Blood|March 1, 2007
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survivalJames R Cerhan, Sophia Wang, Matthew J Maurer, et al.
Emerging Infectious Diseases|April 23, 2014
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United StatesMartin Steinau, Mona Saraiya, Marc T Goodman, et al.
JAMA Network Open|January 9, 2025
Breast Cancer Susceptibility Gene Sequence Variations and Development of Contralateral Breast CancerAnne S Reiner, Gordon P Watt, Kathleen E Malone, et al.
Diseases of the Colon and Rectum|March 25, 2000
Hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in UruguayC Sarroca, N Alfano, G T Bendin, et al.
Journal of the National Cancer Institute|November 1, 2007
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term riskAnil K Chaturvedi, Eric A Engels, Ethel S Gilbert, et al.
Breast Cancer Research and Treatment|July 15, 2009
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE StudyJane C Figueiredo, Robert W Haile, Leslie Bernstein, et al.
Obstetrics and Gynecology|May 3, 2014
Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based populationAbdulrahman K Sinno, Mona Saraiya, Trevor D Thompson, et al.
Pageof 87